Skip to content

This Biotech’s Unique Approach To Drug Development Could Give It The Best Chance Of Beating The Market This Year

When it comes to the author of today’s article’s top biotech stock pick for 2021, an under-the-radar name, he explains that “Many of the reasons to buy [it] could also apply to other biotech stocks, but it’s the company’s unique approach to the unusual business of developing new drugs that makes it [his] top pick this year.” For the stock in question and why the author believes it “has a better chance to beat the market than any of its peers”, CLICK HERE.